Ayman El-Menyar1, Brijesh Sathian2, Bianca M Wahlen3, Husham Abdelrahman4, Ruben Peralta5, Hassan Al-Thani4, Sandro Rizoli4. 1. Department of Surgery, Clinical Research, Trauma & Vascular Surgery, Hamad General Hospital (HGH), Doha, Qatar; Clinical Medicine, Weill Cornell Medical College, Doha, Qatar. Electronic address: aymanco65@yahoo.com. 2. Department of Surgery, Clinical Research, Trauma & Vascular Surgery, Hamad General Hospital (HGH), Doha, Qatar. 3. Department of Anesthesia & Trauma Surgery, HGH, Doha, Qatar. 4. Department of Surgery, Trauma Surgery, HGH, Doha, Qatar. 5. Department of Surgery, Trauma Surgery, HGH, Doha, Qatar; Department of Surgery, Universidad Nacional Pedro Henriquez Urena, Santo Domingo, Dominican Republic.
Abstract
PURPOSE: The purpose of this study was to test the efficacy of prehospital administration of tranexamic acid (TXA) to injured patients on mortality, thromboembolic events and need for blood transfusion in a level 1 trauma center. METHODS: We conducted a retrospective study comparing adult trauma patients receiving or not receiving prehospital TXA between January 2017 and September 2018. Patients not receiving TXA but transfused within 4 h of admission were 1:1 matched to TXA-treated patients for age, sex, injury severity score, head abbreviated injury score, prehospital heart rate and systolic blood pressure. RESULTS: In total 204 patients were included (102 TXA and 102 control), with a mean age of 31 years. On admission, shock index (p = 0.03) and serum lactate (p = 0.001) were greater in the control group, whereas the initial base deficit, hemoglobin levels and EMS time were comparable in both groups. The odd ratio (OR) for shock index ≥0.9 after TXA administration was 0.44 (95% CI 0.23-0.84). The median amount of blood transfusion was greater in the control group [eight units (range 1-40) vs three (range 0-40), p = 0.01] as well as the use of massive blood transfusion [OR 0.35 (95% CI 0.19-0.67)]. In the TXA group, VTE was higher [OR 2.0 (95% CI 0.37-11.40)]; whereas the overall mortality was lower [OR 0.78 (95% CI 0.42-1.45)] without reaching statistical significance. CONCLUSIONS: Prehospital TXA administration is associated with less in-hospital blood transfusion and massive transfusion protocol (MTP). There is no significant increase in the thromboembolic events and mortality, however, further evaluation in larger clinical trials is needed.
PURPOSE: The purpose of this study was to test the efficacy of prehospital administration of tranexamic acid (TXA) to injured patients on mortality, thromboembolic events and need for blood transfusion in a level 1 trauma center. METHODS: We conducted a retrospective study comparing adult traumapatients receiving or not receiving prehospital TXA between January 2017 and September 2018. Patients not receiving TXA but transfused within 4 h of admission were 1:1 matched to TXA-treated patients for age, sex, injury severity score, head abbreviated injury score, prehospital heart rate and systolic blood pressure. RESULTS: In total 204 patients were included (102 TXA and 102 control), with a mean age of 31 years. On admission, shock index (p = 0.03) and serum lactate (p = 0.001) were greater in the control group, whereas the initial base deficit, hemoglobin levels and EMS time were comparable in both groups. The odd ratio (OR) for shock index ≥0.9 after TXA administration was 0.44 (95% CI 0.23-0.84). The median amount of blood transfusion was greater in the control group [eight units (range 1-40) vs three (range 0-40), p = 0.01] as well as the use of massive blood transfusion [OR 0.35 (95% CI 0.19-0.67)]. In the TXA group, VTE was higher [OR 2.0 (95% CI 0.37-11.40)]; whereas the overall mortality was lower [OR 0.78 (95% CI 0.42-1.45)] without reaching statistical significance. CONCLUSIONS: Prehospital TXA administration is associated with less in-hospital blood transfusion and massive transfusion protocol (MTP). There is no significant increase in the thromboembolic events and mortality, however, further evaluation in larger clinical trials is needed.
Authors: José Luiz de Faria; Josué da Silva Brito; Louise Teixeira Costa E Silva; Christiano Tadeu Sanches Mattos Kilesse; Nicolli Bellotti de Souza; Carlos Umberto Pereira; Eberval Gadelha Figueiredo; Nícollas Nunes Rabelo Journal: Neurosurg Rev Date: 2020-06-17 Impact factor: 3.042
Authors: Hassan Al-Thani; Ahammed Mekkodathil; Attila J Hertelendy; Ian Howland; Tim Frazier; Ayman El-Menyar Journal: Int J Environ Res Public Health Date: 2021-04-12 Impact factor: 3.390
Authors: Mahdi Al-Jeabory; Lukasz Szarpak; Kecskes Attila; Michael Simpson; Adam Smereka; Aleksandra Gasecka; Wojciech Wieczorek; Michal Pruc; Maciej Koselak; Wladyslaw Gawel; Igor Checinski; Milosz J Jaguszewski; Krzysztof J Filipiak Journal: J Clin Med Date: 2021-03-03 Impact factor: 4.241